MedPath

The value of transthoracic contrast echocardiography after pulmonary arteriovenous malformation embolizatio

Recruiting
Conditions
Hereditary taemorrhagic telangiectasia (HHT)
Rendu-Osler-Weber disease
10007510
10047066
Registration Number
NL-OMON51776
Lead Sponsor
Sint Antonius Ziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

Adult patients who underwent embolization for pulmonary arteriovenous
malformation and have a follow-up TTCE 6 months after embolization.
(restrospective part)
Adult patients with a treatable pulmonary arteriovenous malformation who will
undergo embolization at the St. Antonius Hospital. (prospective part)

Exclusion Criteria

None

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath